Literature DB >> 10430841

Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis.

A Verrips1, G J Nijeholt, F Barkhof, B G Van Engelen, P Wesseling, J A Luyten, R A Wevers, J Stam, J H Wokke, L P van den Heuvel, A Keyser, F J Gabreëls.   

Abstract

We describe seven Dutch patients from six families with a slowly progressive, mainly spinal cord syndrome that remained for many years the sole expression of cerebrotendinous xanthomatosis (CTX). MRI demonstrated white matter abnormalities in the lateral and dorsal columns of the spinal cord. Post-mortem examination of one of the patients showed extensive myelin loss in these columns. An array of genotypes was found in these patients. We conclude that 'spinal xanthomatosis' is a clinical and radiological separate entity of CTX that should be included in the differential diagnosis of 'chronic myelopathy'.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430841     DOI: 10.1093/brain/122.8.1589

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  22 in total

1.  Mutations in the sterol 27-hydroxylase gene (CYP27A) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis.

Authors:  P T Clayton; A Verrips; E Sistermans; A Mann; G Mieli-Vergani; R Wevers
Journal:  J Inherit Metab Dis       Date:  2002-10       Impact factor: 4.982

2.  Cerebrotendinous xanthomatosis--the spectrum of imaging findings.

Authors:  Arunachalam Pudhiavan; Alka Agrawal; Sangit Chaudhari; Anil Shukla
Journal:  J Radiol Case Rep       Date:  2013-04-01

3.  Look carefully to the heels! A potentially treatable cause of spastic paraplegia.

Authors:  Jonas Alex Saute; Roberto Giugliani; Louise S Merkens; John Pei-Wen Chiang; Andrea E DeBarber; Carolina Fischinger Moura de Souza
Journal:  J Inherit Metab Dis       Date:  2014-08-12       Impact factor: 4.982

4.  Clinical and molecular genetic features of cerebrotendinous xanthomatosis patients in Chinese families.

Authors:  Chen Chen; Yue Zhang; Hui Wu; Yi-Min Sun; Ye-Hua Cai; Jian-Jun Wu; Jian Wang; Ling-Yun Gong; Zheng-Tong Ding
Journal:  Metab Brain Dis       Date:  2017-06-17       Impact factor: 3.584

5.  Spinal form cerebrotendinous xanthomatosis patient with long spinal cord lesion.

Authors:  Ryuta Abe; Yoshiki Sekijima; Tomomi Kinoshita; Tsuneaki Yoshinaga; Shingo Koyama; Takeo Kato; Shu-Ichi Ikeda
Journal:  J Spinal Cord Med       Date:  2016-02-25       Impact factor: 1.985

6.  Nationwide survey on cerebrotendinous xanthomatosis in Japan.

Authors:  Yoshiki Sekijima; Shingo Koyama; Tsuneaki Yoshinaga; Masayoshi Koinuma; Yuji Inaba
Journal:  J Hum Genet       Date:  2018-01-10       Impact factor: 3.172

Review 7.  Disorders of bile acid synthesis.

Authors:  Peter Theodore Clayton
Journal:  J Inherit Metab Dis       Date:  2011-01-13       Impact factor: 4.982

8.  Fine-mapping, mutation analyses, and structural mapping of cerebrotendinous xanthomatosis in U.S. pedigrees.

Authors:  M H Lee; S Hazard; J D Carpten; S Yi; J Cohen; G T Gerhardt; G Salen; S B Patel
Journal:  J Lipid Res       Date:  2001-02       Impact factor: 5.922

9.  Clinical relevance and neurophysiological correlates of spasticity in cerebrotendinous xanthomatosis.

Authors:  A Mignarri; S Rossi; M Ballerini; G N Gallus; M Del Puppo; P Galluzzi; A Federico; M T Dotti
Journal:  J Neurol       Date:  2010-11-21       Impact factor: 4.849

Review 10.  Hereditary spastic paraparesis in adults associated with inborn errors of metabolism: a diagnostic approach.

Authors:  F Sedel; B Fontaine; J M Saudubray; O Lyon-Caen
Journal:  J Inherit Metab Dis       Date:  2007-10-22       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.